$ABUS 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Other Events WARMINSTER, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced that the Company was ...
21 Aug 2026	8-K: Other Events
12 Aug 2026	8-K: Results of Operations and Financial Condition
16 Jul 2026	8-K: Termination of a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
27 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
13 May 2026	8-K: Results of Operations and Financial Condition
15 Apr 2026	8-K: Other Events
23 Mar 2026	8-K: Results of Operations and Financial Condition
03 Mar 2026	8-K: Entry into a Material Definitive Agreement; Other Events
20 Feb 2026	8-K: Other Events
06 Feb 2026	8-K: Other Events
16 Jan 2026	8-K: Other Events
11 Dec 2025	8-K: Other Events
13 Nov 2025	8-K: Results of Operations and Financial Condition; Other Events
07 Oct 2025	8-K: Other Events
10 Sep 2025	8-K: Other Events
06 Aug 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
25 Jun 2025	8-K: Termination of a Material Definitive Agreement; Other Events
23 May 2025	8-K: Submission of Matters to a Vote of Security Holders
14 May 2025	8-K: Results of Operations and Financial Condition

Comments